Long-Term Binge and Escalating Ethanol Exposure Causes Necroinflammation and Fibrosis in Rat Liver

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 2, 2013, Pages 213-222

  Zhou, Jun Ying ^a   Jiang, Zhi An ^a   Zhao, Cai Yan ^a   Zhen, Zhen ^a   Wang, Wei ^a   Nanji, Amin A ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Alcoholic Liver Disease; Cyclooxygenase; Hypoxia Inducible Factor 1; Nitrosative Stress; Oxidative Stress

Indexed keywords

ALCOHOL; COLLAGEN TYPE 1; CYCLOOXYGENASE 2 INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; FATTY LIVER; HEPATITIS; LIVER; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; LONG TERM EXPOSURE; MALE; NITROSATIVE STRESS; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; BINGE DRINKING; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINES; ETHANOL; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER; LIVER CIRRHOSIS; MALE; NECROSIS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PROCOLLAGEN; RATS; RATS, WISTAR; TYROSINE;

RATTUS;

EID: 84873245041     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2012.01936.x     Document Type: Article

References (51)

1. Albano E, French SW, Ingelman-Sundberg M (1999) Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci 4:D533-D540.
2. Arteel GE (2003) Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124:778-790.
3. Arteel GE, Iimuro Y, Yin M, Raleigh JA, Thurman RG (1997) Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology 25:920-926.
4. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209-218.
5. Carson EJ, Pruett SB (1996) Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol. Alcohol Clin Exp Res 20:132-138.
6. Cederbaum AI, Lu Y, Wu D (2009) Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 83:519-548.
7. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539-541.
8. Cook-Johnson RJ, Demasi M, Cleland LG, Gamble JR, Saint DA, James MJ (2006) Endothelial cell COX-2 expression and activity in hypoxia. Biochim Biophys Acta 1761:1443-1449.
9. Corso CO, Gundersen Y, Dorger M, Lilleaasen P, Aasen AO, Messmer K (1998) Effects of the nitric oxide synthase inhibitors N(G)-nitro-L-arginine methyl ester and aminoethyl-isothiourea on the liver microcirculation in rat endotoxemia. J Hepatol 28:61-69.
10. Crabbe JC, Harris RA, Koob GF (2011) Preclinical studies of alcohol binge drinking. Ann N Y Acad Sci 1216:24-40.
11. Csiki I, Yanagisawa K, Haruki N, Nadaf S, Morrow JD, Johnson DH, Carbone DP (2006) Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer. Cancer Res 66:143-150.
12. Fidler TL, Bakner L, Cunningham CL (2004) Conditioned place aversion induced by intragastric administration of ethanol in rats. Pharmacol Biochem Behav 77:731-743.
13. French SW, Miyamoto K, Tsukamoto H (1986) Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res 10:13S-19S.
14. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875.
15. Jung F, Palmer LA, Zhou N, Johns RA (2000) Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86:319-325.
16. Kaplowitz N, Tsukamoto H (1996) Oxidative stress and liver disease. Prog Liver Dis 14:131-159.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321.
18. Kumagai T, Kawamoto Y, Nakamura Y, Hatayama I, Satoh K, Osawa T, Uchida K (2000) 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem Biophys Res Commun 273:437-441.
19. Leclercq IA, Farrell GC, Schriemer R, Robertson GR (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37:206-213.
20. Leclercq IA, Farrell GC, Sempoux C, dela Pena A, Horsmans Y (2004) Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 41:926-934.
21. Lee KS, Buck M, Houglum K, Chojkier M (1995) Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468.
22. Lieber CS, DeCarli LM (1994) Animal models of chronic ethanol toxicity. Methods Enzymol 233:585-594.
23. Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA (1999) Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem 274:22903-22906.
24. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
25. McKim SE, Gabele E, Isayama F, Lambert JC, Tucker LM, Wheeler MD, Connor HD, Mason RP, Doll MA, Hein DW, Arteel GE (2003) Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125:1834-1844.
26. Meagher EA, Barry OP, Burke A, Lucey MR, Lawson JA, Rokach J, FitzGerald GA (1999) Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 104:805-813.
27. Morikawa A, Kato Y, Sugiyama T, Koide N, Chakravortty D, Yoshida T, Yokochi T (1999) Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect Immun 67:1018-1024.
28. Nanji AA, French SW (2003) Animal models of alcoholic liver disease-focus on the intragastric feeding model. Alcohol Res Health 27:325-330.
29. Nanji AA, Jokelainen K, Fotouhinia M, Rahemtulla A, Thomas P, Tipoe GL, Su GL, Dannenberg AJ (2001a) Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am J Physiol Gastrointest Liver Physiol 281:G1348-G1356.
30. Nanji AA, Jokelainen K, Lau GK, Rahemtulla A, Tipoe GL, Polavarapu R, Lalani EN (2001b) Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration. J Pharmacol Exp Ther 299:832-839.
31. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ (2003) Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am J Physiol Gastrointest Liver Physiol 284:G321-G327.
32. Nanji AA, Khettry U, Sadrzadeh SM, Yamanaka T (1993) Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 142:367-373.
33. Nanji AA, Sadrzadeh SM, Thomas P, Yamanaka T (1994) Eicosanoid profile and evidence for endotoxin tolerance in chronic ethanol-fed rats. Life Sci 55:611-620.
34. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ (1997) Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26:1538-1545.
35. O'Shea RS, Dasarathy S, McCullough AJ (2010) Alcoholic liver disease. Hepatology 51:307-328.
36. Pruett SB, Collier SD, Wu WJ (1998) Ethanol-induced activation of the hypothalamic-pituitary-adrenal axis in a mouse model for binge drinking: role of Ro15-4513-sensitive gamma aminobutyric acid receptors, tolerance, and relevance to humans. Life Sci 63:1137-1146.
37. Rao R (2009) Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50:638-644.
38. Reinke LA, Lai EK, DuBose CM, McCay PB (1987) Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci USA 84:9223-9227.
39. Schild L, Reinheckel T, Reiser M, Horn TF, Wolf G, Augustin W (2003) Nitric oxide produced in rat liver mitochondria causes oxidative stress and impairment of respiration after transient hypoxia. FASEB J 17:2194-2201.
40. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
41. Stephens DN, Duka T (2008) Review. Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 363:3169-3179.
42. Takahashi H, Geoffrion Y, Butler KW, French SW (1990) In vivo hepatic energy metabolism during the progression of alcoholic liver disease: a noninvasive 31P nuclear magnetic resonance study in rats. Hepatology 11:65-73.
43. Thurman RG (1998) II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275(4 Pt 1):G605-G611.
44. Tipoe GL, Liong EC, Casey CA, Donohue TM Jr, Eagon PK, So H, Leung TM, Fogt F, Nanji AA (2008) A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury. Alcohol Clin Exp Res 32:669-682.
45. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-630.
46. Tsukamoto H, Towner SJ, Ciofalo LM, French SW (1986) Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6:814-822.
47. Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514.
48. Wells RG (2005) The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol 39:S158-S161.
49. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gabele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, Thurman RG (2001) The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 31:1544-1549.
50. Yang S, Lin H, Diehl AM (2001) Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol 281:G382-G392.
51. Zhou Z, Sun X, Lambert JC, Saari JT, Kang YJ (2002) Metallothionein-independent zinc protection from alcoholic liver injury. Am J Pathol 160:2267-2274.